CHICAGO--(BUSINESS WIRE)--Errant Gene Therapeutics (“EGT”) announces, that on April 30, 2020, the New York Supreme Court, First Department, Appellate Division unanimously affirmed rulings in EGT’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results